Optune | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

203 results for “Optune”

Trials

View all 146 →

A Study of the Safety and Pharmacokinetics of BRCX014 in Patients With Glioblastoma

21 participants · First posted Sep 27, 2018

Active, not recruiting

Niraparib/TTFields in GBM

30 participants · First posted Jan 9, 2020

Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma

12 participants · First posted Jul 16, 2020

Drugs

View all 13 →

Optive Super

Optive MEGA-3

Optive Lite MDPF

Organizations

ATTUNE HEALTH RESEARCH, INC.

United States

FORTUNE LAND (AUST) PTY LTD

Australia

FORTUNE NATIONAL (HONG KONG) LIMITED

Hong Kong, China

News

View all 40 →

Novocure's Optune Lua Receives Japanese Approval for Advanced NSCLC Treatment

Novocure's Optune Lua Receives FDA Approval for Metastatic Non-Small Cell Lung Cancer

FDA Approves Novocure's Lighter, More Flexible Transducer Arrays for Optune Gio in Glioblastoma

Page 1 of 21